For example, chitosan oligosaccharide (COS)-dendritic polycarbonate (DPC) nanoparticles (CD NPs) can significantly activate TBK1/IRF3 phosphorylation, enhance STING signaling in macrophages and tumor cells, increase M1 TAMs and promote DCs maturation, reduce MDSCs and facilitate CD8 + T cells infiltration thereby reshaping the tumor microenvironment into a pro-inflammatory state (210)
This content is for educational purposes only and is not a substitute for medical advice
3 6 3
Regulation, safety, sourcing, and long term evidence are still concerns, so these approaches require careful medical oversight
For a plain-language overview of how BPC-157 is currently classified from a regulatory standpoint, the U.S
A recent systematic review found that almost all included musculoskeletal studies were animal or laboratory studies, so there is no established human BPC-157 cycle that can be applied to KLOW